Q3 2024 Anupam Rasayan India Ltd Earnings Call Transcript
Key Points
- Anupam Rasayan India Ltd (BOM:543275) maintained its EBITDA margins at 30.1% on a standalone basis for Q3 FY24, despite challenging market conditions.
- The company commercialized six new molecules in Q3 FY24, with a total of 11 new molecules launched in nine months FY24, expected to positively impact revenue in FY25 and FY26.
- Anupam Rasayan India Ltd (BOM:543275) signed a letter of intent worth $61 million (INR507 crores) for the next nine years with a leading Japanese chemical company, showcasing strong future demand.
- The company is investing INR59 crores in a hybrid power plant (wind and solar), expected to reduce energy costs by approximately INR15 crores per year.
- Anupam Rasayan India Ltd (BOM:543275) has a strong focus on sustainability, winning the CII 3R Award for best industry practices in waste management.
- Total revenue for Q3 FY24 stood at INR298 crores, showing a YoY degrowth of 23% on a consolidated basis.
- For the nine months FY24, total revenue was INR1,092 crores, posting a YoY degrowth of 1%, indicating ongoing challenges in the market.
- The agrochemical sector continues to face demand issues and falling raw material prices, impacting revenue and growth.
- Working capital days target of 180 to 200 by end of FY24 is unlikely to be achieved due to demand compression and inventory liquidation challenges.
- Short-term demand is expected to remain subdued, with recovery anticipated only from H1 FY25, indicating near-term revenue pressures.
Ladies and gentlemen, good day, and welcome to the Anupam Rasayan India Limited Q3 FY24 earnings conference call. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Advait Bhadekar. Thank you, and over to you, sir.
Thank you, Viren, and good evening, everyone. Welcome to Anupam Rasayan India Limited Q3 and 9M FY24 earnings conference call. Please note that a copy of our disclosure is available on the Investors section of our website as well as on the stock exchanges. Please do note that anything said on this call which reflects our outlook towards the future, or which could be construed as a forward-looking statement must be reviewed in conjunction with the risks that the company faces.
This conference call is being recorded, and the transcript along with the audio of the same, will be made available on the website of the company and exchanges. Please also note that the audio of the conference call is the copyright
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
